Overview

Trial of Microplasmin Intravitreal Injection for Non-surgical Treatment of Focal Vitreomacular Adhesion. The MIVI-TRUST (TG-MV-006) Trial.

Status:
Completed

Trial end date:
2010-04-01

Target enrollment:

Participant gender:

Summary

The objective of this trial is to evaluate the safety and efficacy of intravitreal microplasmin 125µg dose in subjects wiht focal vitreomacular adhesion.

Phase:

Phase 3

Details

Lead Sponsor:

ThromboGenics

Treatments:

Plasminogen